Aspire Growth Partners LLC bought a new stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,726 shares of the company's stock, valued at approximately $457,000.
A number of other large investors have also recently added to or reduced their stakes in PG. NewSquare Capital LLC increased its holdings in shares of Procter & Gamble by 933.3% during the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock worth $26,000 after purchasing an additional 140 shares during the period. Navigoe LLC acquired a new position in Procter & Gamble in the 4th quarter valued at approximately $31,000. Hoey Investments Inc. lifted its position in shares of Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock worth $33,000 after acquiring an additional 148 shares during the period. LFA Lugano Financial Advisors SA acquired a new position in shares of Procter & Gamble in the fourth quarter valued at $34,000. Finally, Atlantic Private Wealth LLC increased its holdings in Procter & Gamble by 95.3% in the 4th quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock valued at $35,000 after buying an additional 101 shares during the period. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Down 1.1 %
PG traded down $1.74 on Monday, hitting $158.78. 7,574,489 shares of the company were exchanged, compared to its average volume of 7,165,698. The stock's fifty day moving average is $167.36 and its 200-day moving average is $167.93. The Procter & Gamble Company has a 12 month low of $156.58 and a 12 month high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The company has a market cap of $372.27 billion, a PE ratio of 25.28, a PEG ratio of 3.76 and a beta of 0.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. The business had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm's revenue for the quarter was down 2.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.52 earnings per share. Equities research analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Monday, April 21st will be issued a dividend of $1.0568 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $4.23 dividend on an annualized basis and a yield of 2.66%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's dividend payout ratio (DPR) is presently 66.98%.
Analyst Ratings Changes
PG has been the topic of a number of analyst reports. Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Royal Bank of Canada upgraded shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $164.00 to $177.00 in a research report on Friday, April 25th. UBS Group restated a "buy" rating on shares of Procter & Gamble in a research report on Monday, February 10th. Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the company an "overweight" rating in a research note on Friday, April 25th. Finally, Redburn Atlantic lowered Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price target on the stock. in a research report on Thursday. Eight equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average price target of $179.40.
Read Our Latest Report on Procter & Gamble
Insider Activity
In other Procter & Gamble news, CEO Gary A. Coombe sold 35,000 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the completion of the sale, the chief executive officer now owns 22,051 shares of the company's stock, valued at $3,829,817.68. This trade represents a 61.35 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the transaction, the chief executive officer now owns 51,965 shares in the company, valued at approximately $8,386,111.70. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 54,000 shares of company stock valued at $9,330,060 over the last three months. Insiders own 0.18% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.